IL1B and breast carcinoma: Furthermore, neutralizing IL-1ß with anakinra in mice xenografted with triple negative MDA-MB-231 and luminal A MCF-7 breast cancer cell lines reduces the incidence of bone metastases and bone turnover markers expression including TNF-α [42].